KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Other Accumulated Expenses (2016 - 2026)

Eli Lilly filings provide 18 years of Other Accumulated Expenses readings, the most recent being $8.7 billion for Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 130.75% to $8.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $8.7 billion, a 130.75% increase, with the full-year FY2025 number at $8.5 billion, up 32.2% from a year prior.
  • Other Accumulated Expenses hit $8.7 billion in Q1 2026 for Eli Lilly, up from $8.5 billion in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $8.7 billion in Q1 2026 to a low of $2.0 billion in Q3 2022.
  • Median Other Accumulated Expenses over the past 5 years was $3.8 billion (2025), compared with a mean of $4.2 billion.
  • Biggest five-year swings in Other Accumulated Expenses: dropped 23.67% in 2022 and later surged 130.75% in 2026.
  • Eli Lilly's Other Accumulated Expenses stood at $2.8 billion in 2022, then rose by 15.32% to $3.3 billion in 2023, then skyrocketed by 94.95% to $6.4 billion in 2024, then surged by 32.2% to $8.5 billion in 2025, then rose by 2.86% to $8.7 billion in 2026.
  • The last three reported values for Other Accumulated Expenses were $8.7 billion (Q1 2026), $8.5 billion (Q4 2025), and $5.2 billion (Q3 2025) per Business Quant data.